CVS Health (CVS) is under pressure after below-expected 2027 Medicare Advantage rate proposals and fresh U.S. Department of ...

CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth ...

Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.

除了名义费率外，CMS还提议取消与非特定就诊相关联的由保险公司医疗图表审查所得诊断相关的付款。该机构估计，仅此一步就会使2027年付款率降低1.53个百分点。此项变动针对长期争议的“上报编码”问题——监管者指责计划通过图表审查和健康风险评估在没有相应临床就诊的情况下提高风险评分和付款。如果按提案最终确定，风险评分将下降，计划每位成员的收入减少，利润率受压——尤其对那些严重依赖图表审查项目的承保方影 ...

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings release, scheduled for July 30, 2025. A key catalyst behind the recent uptick ...

The reason? CVS is more diversified—they operate retail pharmacies (9,000 locations), Pharmacy Benefit Management (CVS ...

The Trump administration proposed keeping Medicare rates roughly flat this year.

CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance and a favorable regulatory outlook. The company raised its full-year 2025 EPS ...

Health insurer stocks are tumbling after the market close on Monday following a report indicating the Trump administration ...

(Reuters) -CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs. Chief Judge Mitchell Goldberg ...